Compare CBLL & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBLL | CLPT |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 428.8M | 494.6M |
| IPO Year | 2024 | N/A |
| Metric | CBLL | CLPT |
|---|---|---|
| Price | $21.63 | $12.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $25.17 | ★ $27.67 |
| AVG Volume (30 Days) | 596.0K | ★ 607.8K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $82,813,000.00 | $34,332,000.00 |
| Revenue This Year | $37.43 | $18.93 |
| Revenue Next Year | $27.87 | $51.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 37.93 | 12.83 |
| 52 Week Low | $10.01 | $9.76 |
| 52 Week High | $32.75 | $30.10 |
| Indicator | CBLL | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 79.68 | 31.45 |
| Support Level | $19.87 | $13.00 |
| Resistance Level | $24.25 | $13.55 |
| Average True Range (ATR) | 1.10 | 0.71 |
| MACD | 0.31 | 0.14 |
| Stochastic Oscillator | 68.77 | 12.50 |
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.